Share on Facebook
The joint evaluation of the legislation on medicines for children and rare diseases is an important step in the process of assessing the impact of EU rules for these medical areas. Feedback is welcome until 4 January 2019.
Created: 2022-01-17 12:46:00
Category: Public Health
Cancer
Hybrid event - Ensuring Equal Access to All: Cancer in Women - Europe’s Beating Cancer Pla...
Created: 2022-01-14 12:43:55
Category: Public Health
Funding
2022 EU4Health work programme adopted to invest over €835 million in health
https://ec.e...